Assessment of Awareness Regarding Genetic, Hormonal, and Biochemical Factors Associated with Breast Cancer Among a Sample of the Iraqi Community
Article Sidebar
Main Article Content
Abstract
Background: Breast cancer is the most common cancer among women worldwide, and public awareness of its risk factors is essential for promoting early detection and prevention. This study aimed to assess awareness of genetic, hormonal, and biochemical factors associated with breast cancer among a sample of the Iraqi population.
Methods: A descriptive cross-sectional study was conducted between December 2025 and February 2026. A total of 684 participants aged 18–40 years were recruited using convenience sampling. Data were collected through a structured questionnaire adapted from the Breast Cancer Awareness Measure (Breast-CAM). The questionnaire assessed demographic characteristics and participants' awareness of selected breast cancer risk factors. Data were analyzed using descriptive statistics and the Chi-square test.
Results: Overall, 46.8% of participants demonstrated a moderate level of awareness, 31.3% had a high level of awareness, and 21.9% had a low level of awareness. Family history was the most frequently recognized risk factor (90.1%), followed by prolonged oral contraceptive use (41.8%), increasing age (40.4%), and smoking (39.0%). In contrast, awareness of first childbirth after the age of 30 years (14.5%), unhealthy dietary habits (14.5%), and the protective role of breastfeeding (2.2%) was considerably lower.
Conclusions: The study revealed moderate overall awareness of breast cancer risk factors among the Iraqi population. Although awareness of hereditary risk factors was relatively high, important knowledge gaps were identified regarding hormonal, reproductive, dietary, and other modifiable risk factors. These findings highlight the need for targeted educational programs to improve public awareness and support breast cancer prevention and early detection strategies in Iraq.
Article statistics
- Abstract views
- 84
- PDF Downloads
- 17
- Total views
- 101
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in Transdisciplinary Medical, Clinical and Health Research (TMCHR) are licensed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows others to share, copy, distribute, and adapt the work, provided that proper credit is given to the original author(s) and the source.
Authors retain copyright and grant Transdisciplinary Medical, Clinical and Health Research (TMCHR) the right of first publication.
How to Cite
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. DOI: https://doi.org/10.3322/caac.21332
2. Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels. Biomark Res. 2021;9(1):1–12. DOI: https://doi.org/10.1186/s40364-021-00310-y
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. DOI: https://doi.org/10.3322/caac.21660
4. Alagoz O, Lowry KP, Kurian AW, et al. Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J Natl Cancer Inst. 2021;113(11):1484–1494. DOI: https://doi.org/10.1093/jnci/djab097
5. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151–164. DOI: https://doi.org/10.2147/BCTT.S176070
6. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360(6):573–587. DOI: https://doi.org/10.1056/NEJMoa0807684
7. Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol. 2016;43(5):528–535. DOI: https://doi.org/10.1053/j.seminoncol.2016.10.001
8. Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, et al. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer. 2009;100(2):421–425. DOI: https://doi.org/10.1038/sj.bjc.6604830
9. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000;92(4):328–332. DOI: https://doi.org/10.1093/jnci/92.4.328
10. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915–928. DOI: https://doi.org/10.1038/nrc2536
11. Key TJ, Appleby PN, Reeves GK, Roddam AW; Endogenous Hormones and Breast Cancer Collaborative Group. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11(6):530–542. DOI: https://doi.org/10.1016/S1470-2045(10)70095-4
12. Linsell L, Forbes LJL, Burgess C, Kapari M, Thurnham A, Ramirez AJ. Validation of a measurement tool to assess awareness of breast cancer. Eur J Cancer. 2010;46(8):1374–1381. DOI: https://doi.org/10.1016/j.ejca.2010.02.034
13. Kaliyaperumal K. Guideline for conducting a knowledge, attitude and practice (KAP) study. Community Ophthalmol. 2004;4(1):7–9.
14. National Cancer Institute. BRCA gene changes: cancer risk and genetic testing [fact sheet]. Bethesda (MD): National Cancer Institute; 2024.
15. Liu LY, Wang F, Yu LX, Ma ZB, Zhang Q, Gao DZ, et al. Breast cancer awareness among women in Eastern China: a cross-sectional study. BMC Public Health. 2014;14:1004. doi:10.1186/1471-2458-14-1004 DOI: https://doi.org/10.1186/1471-2458-14-1004
16. Kasting ML, Head KJ, Hartsock JA, Sturm LA, Zimet GD. Awareness of breast cancer risk related to a positive family history and alcohol consumption among women aged 15–44 years in the United States. Prev Med Rep. 2020;17:101029. doi:10.1016/j.pmedr.2019.101029 DOI: https://doi.org/10.1016/j.pmedr.2019.101029
17. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. DOI: https://doi.org/10.3322/caac.21763
18. American Cancer Society. Health risks of smoking tobacco. Atlanta (GA): American Cancer Society; 2024.
19. International Agency for Research on Cancer. Combined estrogen–progestogen contraceptives. IARC Monogr Eval Carcinog Risks Hum. 2023.
20. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141–1151. DOI: https://doi.org/10.1016/S1470-2045(12)70425-4
21. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186–194. DOI: https://doi.org/10.3322/caac.21225
22. Farvid MS, Barnett JB, Spence ND. Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies. Br J Cancer. 2021;125(2):284–298. doi:10.1038/s41416-021-01373-2 DOI: https://doi.org/10.1038/s41416-021-01373-2
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet. 2002;360(9328):187–195. DOI: https://doi.org/10.1016/S0140-6736(02)09454-0